- Home
- LNTH vs INTR Comparison
LNTH vs INTR Comparison
Compare LNTH & INTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- INTR
- Stock Information
- Founded
- LNTH 1956
- INTR 1994
- Country
- LNTH United States
- INTR Brazil
- Employees
- LNTH N/A
- INTR N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- INTR
- Sector
- LNTH Health Care
- INTR
- Exchange
- LNTH Nasdaq
- INTR Nasdaq
- Market Cap
- LNTH 3.6B
- INTR 3.7B
- IPO Year
- LNTH 2015
- INTR N/A
- Fundamental
- Price
- LNTH $55.95
- INTR $8.88
- Analyst Decision
- LNTH Buy
- INTR Hold
- Analyst Count
- LNTH 6
- INTR 2
- Target Price
- LNTH $74.50
- INTR $5.55
- AVG Volume (30 Days)
- LNTH 1.7M
- INTR 1.9M
- Earning Date
- LNTH 11-05-2025
- INTR 11-13-2025
- Dividend Yield
- LNTH N/A
- INTR 0.35%
- EPS Growth
- LNTH N/A
- INTR 69.31
- EPS
- LNTH 3.77
- INTR 0.47
- Revenue
- LNTH $1,520,653,000.00
- INTR $974,787,476.00
- Revenue This Year
- LNTH N/A
- INTR $82.82
- Revenue Next Year
- LNTH $2.91
- INTR $21.77
- P/E Ratio
- LNTH $14.59
- INTR $18.62
- Revenue Growth
- LNTH 5.75
- INTR 38.56
- 52 Week Low
- LNTH $47.25
- INTR $3.88
- 52 Week High
- LNTH $118.21
- INTR $9.48
- Technical
- Relative Strength Index (RSI)
- LNTH 57.30
- INTR 54.27
- Support Level
- LNTH $52.21
- INTR $8.29
- Resistance Level
- LNTH $56.53
- INTR $8.81
- Average True Range (ATR)
- LNTH 1.65
- INTR 0.23
- MACD
- LNTH 0.80
- INTR -0.08
- Stochastic Oscillator
- LNTH 91.55
- INTR 54.13
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About INTR Inter & Co. Inc.
Inter & Co Inc operates as a digital bank. The company's segment includes Banking & Spending; Investments; Insurance Brokerage; and Inter Shop. It generates maximum revenue from the Banking & Spending segment which comprises a wide range of banking products and services, such as checking accounts, cards, deposits, loans and advances, and other services, which are available to the clients by means of Inter's mobile application.